Claris Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 120.51 Cr
as on 04-05-2024
- Paid Up Capital ₹ 54.57 Cr
as on 04-05-2024
- Company Age 30 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
- Satisfied Charges ₹ 3,276.28 Cr
as on 04-05-2024
- Revenue -91.01%
(FY 2021)
- Profit 94.55%
(FY 2021)
- Ebitda 78.42%
(FY 2021)
- Net Worth -2.40%
(FY 2021)
- Total Assets -1.99%
(FY 2021)
About Claris Lifesciences
- CIN/LLPIN
U85110GJ1994PLC022543
- Company No.
022543
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
19 Jul 1994
- Date of AGM
28 Sep 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Claris Lifesciences Limited offer?
Claris Lifesciences Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Injection, Pain Relief Drugs & Pharmaceuticals, Anesthetic, Natural and Synthetic Resins, Resins, Surgical & ICU Equipments, Dialysis Machine, Cardiovascular Drugs & Medication, Immunosuppressive Drugs.
Who are the key members and board of directors at Claris Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Handa  | Managing Director | 19-Feb-2001 | Current |
| K Kanjaria | Company Secretary | 13-Apr-2013 | Current |
| Chandrasingh Purohit | CFO | 09-May-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Surrinder Kapur | Director | 26-Sep-2008 | Current |
| Chandrasingh Purohit | Whole-Time Director and Cfo | 03-Jul-2009 | Current |
Anup Shah  | Director | 23-Feb-2013 | Current |
| Aditya Handa | Director | 13-Jun-2006 | Current |
| Shyamsunder Sharma | Director | 20-May-2017 | Current |
Financial Performance and Corporate Structure Insights of Claris Lifesciences.
Claris Lifesciences Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 91.01% decrease. The company also saw a substantial improvement in profitability, with a 94.55% increase in profit. The company's net worth dipped by a decrease of 2.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Claris Lifesciences?
In 2021, Claris Lifesciences had a promoter holding of 99.29% and a public holding of 0.71%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Credit Suisse Ag Creation Date: 20 Dec 2017 | ₹390.00 Cr | Satisfied |
Credit Suisse Ag Creation Date: 20 Dec 2017 | ₹390.00 Cr | Satisfied |
Punjab National Bank Creation Date: 30 Sep 2016 | ₹20.00 Cr | Satisfied |
How Many Employees Work at Claris Lifesciences?
Claris Lifesciences has a workforce of 162 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Claris Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Claris Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED.webp){kind=small}
